Lineage Cell Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q2 2019 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Lineage Cell Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q2 2019 to Q2 2022.
  • Lineage Cell Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending June 30, 2022 was $330K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2022 $330K Jun 30, 2022 10-Q 2022-08-11
Q3 2019 $1.18M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.47M Jun 30, 2019 10-Q 2019-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.